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Abstract 
Single servings of coffee beverage containing low (412 µmol), medium (635 
µmol) and high (795 µmol) amounts of chlorogenic acids were administered to 
eleven healthy volunteers in a double-blind randomised controlled trial. Analysis 
of plasma and urine collected for 24-h revealed the presence of 12 metabolites in 
plasma and 16 metabolites in urine, principally in the form of sulphates, and to a 
lesser extent glucuronides of caffeic, ferulic, dihydrocaffeic and dihydroferulic 
acids, as well as intact feruloylquinic and caffeoylquinic acids, and sulphated 
caffeoylquinic acid lactones. Median values of peak plasma concentrations after 
increasing doses of chlorogenic acids were 1088, 1526 and 1352 nM. In urine the 
median amounts of metabolites excreted after 24-h following consumption of the 
three coffees were 101, 160 and 125 µmol, accounting for 24%, 25% and 16% of 
the doses ingested. Peak plasma concentration and urinary excretion values 
showed trends towards a reduced bioavailability of chlorogenic acids associated 
with the highest dose ingested, when expressed as percentages of intake. 
Potential biomarkers of coffee intake were identified as feruloylquinic acids and 
sulphated caffeoylquinic acid lactones in plasma and urine with positive 
moderate to strong coefficients of determination for peak plasma concentrations 
(0.60-0.81) and amounts excreted in urine (0.36-0.73) (P < 0.05). 
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1. Introduction 
Coffee is widely consumed throughout the world and the beverage contains high 
levels of chlorogenic acids with a single shot of espresso from commercial outlets 
providing between 24 and 422 mg.1 Although occurring in a diversity of plant-
derived foods, coffee is the major dietary source of chlorogenic acids for many 
people.2  Chlorogenic acids are a family of non-flavonoid compounds, comprising 
quinate esters of hydroxycinnamic acids such as caffeic, ferulic, and p-coumaric 
acids. The main chlorogenic acid classes in coffee are caffeoylquinic acids (CQAs), 
feruloylquinic acids (FQAs), p-coumaroylquinic acids (pCoQAs), dicaffeoylquinic 
acids (diCQAs), and caffeoylferuloylquinic acids (CFQAs). In addition, 
caffeoylquinic acid lactones (CQLs) and feruloylquinic acid lactones (FQLs), 
products of roasting, can also occur in coffee in significant amounts.3  Depending 
on the position of the hydroxycinnamic acid on the quinic acid moiety, a wide 
range of different isomers occur in coffee, with the predominant compounds 
being 3-, 4- and 5-CQAs.4 
A limited number of studies have investigated the bioavailability of coffee 
chlorogenic acids in human subjects. Nardini et al.5 reported an increase of 
conjugated caffeic acid in human plasma, reaching a maximum concentration 1 h 
after the ingestion of 200 mL of coffee. Increased amounts of ferulic acid, 
isoferulic acid, vanillic acid (3-methoxy-4-hydroxybenzoic acid), dihydroferulic 
acid, hippuric acid and 3-hydroxyhippuric acid were detected in urine samples of 
five male subjects, after three ingestions of two cups of coffee at 4 h intervals.6  A 
wide range of metabolites produced in vivo after coffee intake or chlorogenic 
acids ingestion has been reported in previous detailed bioavailability studies 
along with only low nM levels of CQAs and FQAs appearing in plasma and urine 
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in healthy subjects and volunteers with an ileostomy, and allowed distinguishing 
between events occurring in the small and large intestine.7,8 The low nM levels of 
CQAs and FQAs in plasma is also supported by other studies which have involved 
enzymic deglucuronidation and desulfation of the plasma samples.9 
The aim of the current study was to expand the earlier work of Stalmach 
et al.7,8 and to investigate the impact on the plasma pharmacokinetic profiles and 
urinary excretion of chlorogenic acid-derived metabolites after the acute 
ingestion by human volunteers of three instant coffees containing 412, 635 and 
795 µmol of chlorogenic acids per 200 mL serving.   
2. Results 
2.1. Analysis of coffees 
The quantities of chlorogenic acids in 200 mL-servings of the three instant 
coffees (coffee I, II and III) fed to volunteers are summarised in Table 1.  
Identifications of the chlorogenic acids were based on MS2 fragmentation 
patterns of ions at m/z 353 (CQAs)1,  m/z 367 (FQAs), m/z 337 (p-CoQAs) and 
m/z 515 (diCQAs), according to Clifford et al.10,11  The identity of 3- and 4-CQAL 
was ascertained by both the MS2 profiles of their ions at m/z 335 and co-
chromatography with standards.  The levels of chlorogenic acids in the coffees 
ranged from 412 ± 9 to 795 ± 14 µmol, and consisted in CQAs (63 - 74 %), FQAs 
(13 - 18 %), CQALs (5 - 14 %), diCQAs (3 - 8 %) and p-CoQAs (1 - 2 %).  The 2-
fold difference between the highest and the lowest levels was mainly due to 
significantly greater amounts of CQAs, FQAs, diCQAs and p-CoQAs in coffee III 
                                                
1
 There is much confusion over the names of caffeoylquinic acids with many suppliers, including 
Sigma, using non-IUPAC nomenclature. They refer to chlorogenic acid as 3-O-caffeoylquinic acid 
when it is 5-O-caffeoyquinic acid while their crytochorogenic acid, marketed as 5-O-caffeoyquinic 
acid, is the 3-O-isomer 
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which contained 795 ± 14 µmol of chlorogenic acids. Coffee II with intermediate 
levels of chlorogenic acids (635 ± 3 µmol) contained significantly more FQAs 
than the other two beverages (117 µmol compared to 103 and 67 µmol), as well 
as higher levels of lactones (77 µmol compared to 57 and 40 µmol) per serving 
(Table 1). 
2.2. Identification of chlorogenic acid derivatives and metabolites in 
plasma and urine samples 
The identification and quantification of chlorogenic acid derivatives and 
metabolites circulating in plasma and excreted in urine was initially carried out 
on samples collected following the ingestion of coffee I, a commercial instant 
coffee that contains 412 µmol of chlorogenic acids per 200 mL serving.  A total of 
21 metabolites, principally sulphates and glucuronides were identified by HPLC-
MSn in the 0-24 h plasma and urine samples. The identifications, summarised in 
Table 2, were achieved using HPLC-MS3. The resulting MS2 and MS3 daughter 
ions were then compared to the fragmentation of either the available standards 
or, in the case of the chlorogenic acids, to their detailed, published MSn 
fragmentation patterns.10,11 The identity of metabolites of chlorogenic acids in 
plasma and urine samples was also ascertained by comparing their retention 
time with those of 3ʹ-O- and 4ʹ-O- sulphate and glucuronide standards.  Full 
details of the basis of the identifications of the metabolites can be found in an 
earlier publication.7 There are minor differences in the complex urinary 
metabolite profiles obtained in the two studies but this involves trace 
components, such a dihydroisoferulic acid-3′-O-glucuronide which was not 
detected in quantifiable amounts in the current investigation, rather than major 
metabolites. 
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2.2. Chlorogenic acid intake and plasma metabolites  
Twelve metabolites were detected in plasma following the ingestion of the three 
coffees containing different amounts of chlorogenic acids. Peak plasma 
concentrations (Cmax), time to reach Cmax (Tmax), area-under-the-curve (AUC) and 
apparent elimination half life2 (T1/2) values were measured following increasing 
intakes. The pharmacokinetic parameters are summarised in Figure 1 and Table 
3. 
The metabolic profile of the circulating chlorogenic acid metabolites can 
be divided into two distinct groups according to their time of appearance in 
plasma, following coffee intakes (Figure 1). Intact feruloylquinic acids, as well as 
the sulphated lactones, 5-CQA and sulphated ferulic and caffeic acids reached 
peak plasma concentrations (Cmax) between 0.5 and 1.0 h after intake (Table 3). 
The only exception was ferulic acid-4′-O-sulphate, as a second Cmax peak 
appeared in plasma, after 4.0 h. Free and sulphated dihydroferulic and 
dihydrocaffeic acids appeared in plasma at later time points and reached their 
Cmax between 4.0 and 6.0 h. Their Cmax values were also higher, ranging from 33 
(26; 41) nM3 (ferulic acid-4ʹ-O-sulphate after ingestion of coffee I) to 518 (462; 
771) nM (dihydroferulic acid after ingestion of coffee III). In contrast, Cmax values 
of the other compounds ranged from 5.4 (4.5; 5.9) nM (5-FQA after coffee I) to 
126 (111; 195) nM (ferulic acid-4′-O-sulphate after coffee II).  The dihydroferulic 
and dihydrocaffeic acids also seemed to remain in circulation for a longer period 
of time, with T1/2 times ranging from 0.7 (0.4; 0.8) h (dihydrocaffeic acid after 
                                                
2
 A true T1/2 value can be determined only by intravenous dosing of a metabolite. Assessments 
based on elimination after oral dosing overestimate the T1/2 because the metabolite is still 
entering the circulatory system when the elimination is being estimated.  
3
 Expressed as median and interquartiles (Q1; Q3) values 
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ingestion of coffee I) to 3.9 (3.0; 8.4) h (ferulic acid-4′-O-sulphate after coffee III). 
This large range of T1/2 values probably reflects the lack of data points between 8 
h and 24 h time points of blood collection. The other compounds appeared to 
have a more rapid turnover, with T1/2 values ranging from 0.2 (0.2; 0.3) h (5-CQA 
after coffee II) to 1.2 (0.8; 3.4) h (caffeic acid-3′-O-sulphate after coffee I). 
 The total Cmax of compounds with an early Tmax of 0.5-1 h (sulphates of 
caffeic and ferulic acids, sulphates of 3- and 4-caffeoylquinic acid-lactones, 5-CQA 
and FQAs) with increasing dose were 261, 510 and 244 nM, respectively. The 
Cmax of compounds with a later Tmax of 4-6 h (free and sulphated dihydrocaffeic 
and dihydroferulic acids and second Cmax of ferulic acid-4′-O-sulphate) following 
the increasing doses were 808, 1242 and 1164 nM.  AUC values for 
dihydrocaffeic acid-3ʹO-sulphate and free dihydroferulic acid and were 
significantly different between the lowest and highest intakes, with values of 
1787 (712; 3210) nmol.h.L-1 and 3839 (3002; 7302) nmol.h.L-1 for dihydrocaffeic 
acid-3ʹO-sulphate and 2845 (2255; 3210) nmol.h.L-1 and 4549 (3688; 7834) 
nmol.h.L-1 for dihydroferulic acid, respectively. The time to reach Cmax as well as 
T1/2 for each compound did not differ with the increasing doses. The only CQA 
that could be quantified in plasma was the main compound in the coffee 
beverage, namely 5-CQA, with Cmax of 11 (5.9; 13) nM following the intake of 795 
µmol (Table 3). 
2.3. Chlorogenic acid intake and urinary excretion of metabolites 
A total of 16 metabolites were quantified in the urine samples following 
increasing doses of the coffee chlorogenic acids. The amounts excreted as well as 
percentages relative to the levels ingested are summarised in Table 4.  The main 
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compounds excreted were dihydrocaffeic acid-3′-O-sulphate, with levels 
excreted ranging from 6.0 % to 8.7 % of the ingested chlorogenic acids. The 
excretion of other metabolites ranged as follows:  feruloylglycine (3.4 – 4.5 %), 
dihydroferulic acid-4′-O-sulphate (2.0 – 2.8 %), ferulic acid-4′-O-sulphate (2.0 - 
2.4 %), dihydroferulic acid (1.3 - 2.1 %), isoferulic acid-3′-O-glucuronide (1.1 - 
1.4 %) and caffeic acid-3′- and 4′-O-sulphates (0.5 - 1.5 %). The total amounts 
excreted in the 24-h urine samples increased with increasing intake from 101 
(82; 119) to 160 (91; 211) to 125 (109; 241) µmol. The percentages excreted, 
relative to intake at 24.4 %, 25.2 % and 15.7 % of the dose, were not significantly 
different, reflecting a large inter-individual variability. 
 Levels of FQAs excreted for 24-h after coffee intake ranged between 0.61 
µmol (5-FQA after intermediate levels coffee) and 9.28 µmol (3-FQA after 
intermediate levels coffee). When expressed as a percentage of intake, levels of 
3-FQA excreted ranged between 4.6 % (high dose) and 6.0 % (low dose), 
whereas levels of 4-FQA ranged between 2.7 % (intermediate dose) and 5.2 % 
(low dose) and lowest excretion levels were observed for 5-FQA (1.8 % following 
intermediate dose and 3.3 % after intake of low dose). Median, ranges and 
interquartile values are displayed in Figure 2. 
2.4. Correlation between doses ingested and levels of metabolites in 
plasma and urine 
Correlation between the doses of chlorogenic acids ingested and levels of parent 
compounds and metabolites quantified in plasma and urine after intake was 
assessed using Spearman’s rank correlation and results are displayed in Table 5. 
Compounds and metabolites significantly associated with increasing doses of 
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chlorogenic acids administered were the FQAs and CQAL-S in both plasma and 
urine, with moderate to strong positive association (correlation coefficients 
ranging from 0.362 for 5-FQA in urine to 0.807 for 3-FQA in plasma, p < 0.05). 
These metabolites showed an increase with the dose ingested, as shown in 
Figures 3 and 4. Urinary levels of ferulic acid-4ʹ-O-sulphate and isoferulic acid-3ʹ-
O-glucuronide also significantly increased with increasing intake of chlorogenic 
acids, with correlation coefficients of 0.409 (p = 0.018) and 0.507 (p = 0.003). 
3. Discusssion 
Following the ingestion of coffee there was extensive metabolism of chlorogenic 
acids.  The probable pathways involved in the proximal and distal sections of the 
gastrointestinal tract, based on feeding studies with volunteers with and without 
an intact functioning colon, have been elucidated by Stalmach et al.7,8  
Despite being major components in the coffee, and in contrast to the 
findings of Monteiro et al. 12  and Farah et al.,13 in the current study only trace 
amounts of one of the three CQAs, 5-CQA, appear in the circulatory system. 
Plasma did however contain low levels of all three FQAs (Figure 1) with 
absorption occurring, as with 5-CQA, in the small intestine. 5-CQA, which is 
stable when incubated with gastric juice,6,14 along with the other CQAs, is 
probably subjected to the action of esterases in the wall of the small intestine15,16 
releasing caffeic acid which is converted to caffeic acid-3′-O-sulphate before 
entering the blood stream. It is possible that 3- and 4-CQAL and diCQAs could 
also be hydrolysed in the small intestine and contribute to the caffeic acid pool. 
The rapid appearance of ferulic acid-4′-O-sulphate in plasma (Fig. 1) could be the 
result of the FQAs following a parallel pathway being converted to ferulic acid 
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and then ferulic acid-O-sulphate, although methylation of caffeic acid via 
catechol-O-methyltransferase (COMT), as well as the conversion of CQAs to 
FQAs, could also contribute to the ferulic acid pool.  Most ferulic acid passes 
across the small intestine in the unmodified, unconjugated aglycone form,17 
implying that phase II sulphation of the hydroxycinnamate occurs mainly in the 
liver. 
Analysis of ileal fluid collected after acute consumption of the lower dose 
by ileostomists indicated that in volunteers with a functioning colon ~70 % of 
the ingested chlorogenic acids will pass from the small to the large intestine,8 
also supported when higher amounts of chlorogenic acids were administered.18  
In vitro faecal fermentations have shown the breakdown of caffeoyl- and 
feruloylquinic acids, respectively, to caffeic acid and ferulic acid, which, via 
reduction of the 2,3 double bond on the aliphatic chain, are then converted to 
their dihydro derivatives by a bacterial reductase prior to phase II sulphation, 
and to a lesser degree glucuronidation, mediated by mammalian rather than 
bacterial enzymes.19  The current study provides evidence of substantial 
absorption and metabolism in the colon, with Cmax values mostly well in excess of 
those obtained with compounds absorbed in the small intestine, being observed 
4.0-6.0 h after coffee intake for dihydroferulic acid-4′-O-sulphate, dihydrocaffeic 
acid-3′-O-sulphate as well as dihydroferulic acid and dihydrocaffeic acid (Table 
3). 
The plasma pharmacokinetic data in Table 3 and Figure 1 reveals the 
appearance in the circulatory system of dihydrocaffeic acid, dihydrocaffeic acid-
3′-O-sulphate, dihydroferulic acid and dihydroferulic acid-4′-O-sulphate 4.0-6.0 h 
after drinking coffee. This is in agreement with the role of the colonic microflora 
Page 10 of 35Food & Function
 11
in the conversion of CQAs to caffeic acid and dihydrocaffeic acid and FQAs to 
ferulic acid and dihydroferulic acid demonstrated with the in vitro based study of 
Ludwig et al.19  The large intestine is not a site for the in vivo sulphation of either 
hydroxycinnamates,17 or flavonols.20 or The sulphation of dihydrocaffeic acid 
and dihydroferulic acid, therefore, probably occurs in the liver after their 
absorption into the circulatory systems. The presence of substantial amounts of 
both free and sulphated dihydroferulic and dihydrocaffeic acids in plasma (Fig. 
1) is in keeping with this proposal. 
Peak plasma concentrations and urinary excretion could be divided into 
metabolites absorbed in the small intestine and large intestine, and when 
expressed as a percent of intake, there was a significant trend towards a reduced 
absorption in the small intestine associated with the highest dose ingested 
(Table 6). Similarly, urinary excretion of metabolites absorbed in the small 
intestine accounted for 5.9% (low dose), 5.4% (medium dose) and 3.9% (high 
dose), suggesting a reduced bioavailability of coffee chlorogenic acids after 
consumption of a higher dose.  This is in line with a phenomenon noted by Erk et 
al.18 or in an investigation with ileostomists, demonstrating an increased 
gastrointestinal transit time associated with the highest dose of chlorogenic 
acids ingested, albeit at doses that were 2.6 fold (low dose) and 5.7 fold (high 
dose) greater than those used in the current study. They observed an effect 
across all three doses, whereas in the current study, we observed a reduced 
bioavailability of coffee chlorogenic acids at the higher dose of chlorogenic acids 
ingested (795 µmol). This was however not reflected on the Tmax values of the 
various circulating metabolites identified. 
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Despite the low plasma and urine concentrations of intact CQAs observed, 
more of the FQAs were detected in circulation and excreted in urine across all 
three doses administered. Using an in vitro culture of gastric epithelial 
monolayers, Farrell et al.21 showed that FQAs are recovered to a lesser extent to 
the basal side of the cells compared to the CQAs. The presence of catechol-O-
methyltransferase in gastric21 and intestinal epithelial cells22 may explain the 
presence of FQAs in circulation, as a result of methylation of the absorbed CQAs. 
In the current study, the urinary excretion levels of 3-FQA were consistently 
higher compared to those of 4-FQA and 5-FQA, across all three coffees (Fig. 2). 
This may have resulted from either extensive in vivo isomerisation from 5-FQA 
to the 4- and 3-acyl, as previously observed in ileostomy volunteers23 and/or 
from a preferential absorption with possible involvement of an active transport 
processed as discussed for the gastric absorption of 4-CQA and 4-FQA over the 5-
acyls.21 
Overall, the excretion of metabolites in urine after ingestion of 
chlorogenic acids ranged from 15.7 to 25.2 % of intake (Table 4), indicating that 
the coffee chlorogenic acids are absorbed and excreted to a much greater extent 
than many other dietary flavonoids and phenolic compounds.24  In the three 
coffee feeds total Cmax values were 1088 (759; 1372), 1526 (919; 2110) and 1352 
(1211; 2291) . As noted in other studies with dietary (poly)phenolics this 
suggests that metabolites and related compounds absorbed into the circulatory 
system do not accumulate to any extent as they are treated by the body as 
xenobiotics and rapidly removed by renal excretion. 
Biomarkers of (poly)phenol consumption may be a useful tool to assess 
dietary intake of certain compounds with potential benefits to human health, 
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thus allowing estimating long-term consumption with better accuracy than 
dietary questionnaires.25 The data obtained in the current study with coffee are 
summarised in Table 5, and show that levels of FQAs and CQAL-O-sulphates in 
plasma and urine significantly and positively correlate with increasing intake of 
chlorogenic acids. These could serve as biomarkers of coffee intake, as their 
concentration in body fluids is sensitive to changes in coffee intake, and are also 
specific to coffee.26 This is in contrast with the dihydrocaffeic acid and 
dihydroferulic acid metabolites, which are detected in a wide range of values 
between individual volunteers, and are also produced from a range of dietary 
(poly)phenolic compounds.27,28 The combined presence of these quinic acid ester 
metabolites in plasma and urine are convenient biomarkers of coffee 
consumption even after relatively low doses of intake. 
4. Experimental 
4.1. Chemicals   
Ferulic acid, 5-CQA, dihydrocaffeic acid, sinapic acid, and L-ascorbic acid were 
purchased from Sigma Aldrich Co Ltd (Poole, Dorset, UK). Caffeic acid was 
obtained from AASC Ltd (Southampton, UK), and dihydroferulic acid from Alfa 
Aesar (Heysham, Lancashire, UK. EDTA and HPLC grade formic acid were 
purchased from Fisher Scientific Ltd (Loughborough, Leicestershire, UK), 
methanol and acetonitrile from Rathburn Chemicals (Walkerburn, Scotland), and 
acetic acid from WWR International Ltd (Poole, Dorset, UK).  3- and 4-
caffeoylquinic acid lactones, 3- and 4-β-O-glucuronidated ferulic, isoferulic, 
caffeic, dihydrocaffeic, dihydroferulic and dihydro(iso)ferulic acids, 3- and 4-O-
sulphated ferulic, caffeic, dihydrocaffeic and dihydroferulic acids were 
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synthesized as described previously.29 Feruloylglycine and isoferuloylglycine 
were prepared by methods outlined in an earlier publication.8 
4.2. Feeding study design   
The feeding study was a double-blinded randomised cross-over trial with a 
washout period of two weeks between treatment, and involved healthy 
participants fed a single serving of 200 ml of coffee beverage, containing various 
doses of chlorogenic acids. The instant coffee powders were contained in colour-
coded sachets and neither the researchers involved in the feeding trial and 
collection of body fluids or the volunteers were made aware of the contents prior 
to the end of the project. 
 The criteria for volunteers to participate in the study were to be in good 
health, non-smoker, and not pregnant. Eleven volunteers participated in the 
study (eight male and three female) and were aged 19-35 years, with an average 
height of 1.70 ± 0.13 m (mean ± standard deviation), an average weight of 70.6 ± 
11.5 kg, and an average BMI of 24.3 ± 2.3 kg/m2. 
The study and protocol were reviewed by Glasgow Royal Infirmary NHS 
Research Ethics Committee. The volunteers followed a low polyphenol diet for 
48 h prior to the beginning of the study. On the night preceding the trial, the 
subjects stopped consuming food after dinner (8 pm) and came to the trial unit 
at 8.30 am the next day, in a fasted state. Water was the only liquid allowed ad 
libitum. The 200 ml of coffee beverages were made as described below. The 
participants were encouraged to drink the beverage within 5 min after it reached 
a suitable temperature for consumption. All urine excreted over 24 h was 
collected over the periods: 0-2 h, 2-5 h, 5-8 h and 8-24 h, and blood samples 
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were collected in heparin tubes prior (0 h) and post-ingestion at 0.5, 1, 1.5, 2, 3, 
4, 6, 8 and 24 h.  
A standard lunch, containing low levels of phenolic and polyphenolic 
compounds was provided after the 3 h samples were collected. The amount 
consumed was not limited, water was available all day and the subjects were 
encouraged to drink. After the 8 h samples were collected, the volunteers 
remained on the low-phenolic diet until the next morning, prior to collection of 
the 24-h time point samples. The volumes of urine excreted were measured, and 
aliquots were stored at –80°C and, likewise, plasma samples were sub-divided 
into 1 ml aliquots which were stored at –80°C prior to analysis. 
4.3. Analysis of coffee, plasma and urine  
 The instant coffees fed to the volunteers were supplied by the Nestlé Research 
Centre (Vers-chez-les-Blanc, Lausanne, Switzerland). Beverages were prepared 
by adding 200 ml of boiled distilled water to 3.4 g of powdered instant coffee and 
aliquots were stored at –80°C prior to analysis. Samples were defrosted and 
centrifuged at 16,110 g for 3 min at 4°C, and diluted 50-fold with distilled water 
and 100 µl aliquots analysed in triplicate by HPLC-PDA-MSn. 
Urine samples were defrosted and centrifuged at 16,110 g for 3 min at 
4°C, prior to the triplicate analysis of 20 µl aliquots by HPLC-PDA-MSn. 
Plasma samples were defrosted and were extracted based on the method 
of Day et al.30 Plasma (450 µl), acidified with 13.5 µl of 50 % aqueous formic acid, 
was added drop-wise to a 1125 µL of acetonitrile to which had been added 50 µl 
of 10 % (m/v) ascorbic acid containing 0.5 µM EDTA, and 1 µg of sinapic acid 
which was used as an internal standard. Samples were vortexed for 30 sec every 
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2 min over a 10 min period before centrifuging at  
1,500 g for 20 min at 4° C. The supernatant was decanted and the pellet re-
extracted with 1,125 µl of methanol and after centrifugation the two 
supernatants were combined and reduced to dryness under a stream of nitrogen 
at 35°C. The dried samples were then re-suspended in 250 µL of 0.1% aqueous 
formic acid containing 10% methanol, and centrifuged at 4°C for 20 min at 
16,110 g in a 0.2 µm Eppendorf filter. Duplicate 100 µl volumes were analyzed 
by HPLC-PDA-MSn.  
Extraction efficiency experiments were carried out and typical values of 
55 ± 1.5 % were achieved for sinapic acid. Extraction efficiencies were also 
determined for 5-CQA, caffeic acid, ferulic acid, dihydrocaffeic and dihydroferulic 
acids, and for 3- and 4-CQA lactones. Ratios of the individual recoveries relative 
to sinapic acid were computed and used as correction factors in the 
quantification of metabolites in the plasma samples. 
4.4. HPLC-PDA-MSn   
Chlorogenic acids and related compounds were analyzed using a Surveyor HPLC 
with a PDA detector and a LCQ Duo ion trap mass spectrometer fitted with an 
electrospray interface (Thermo Finnigan, San Jose, USA). Separations were 
performed at 40°C using a SYNERGI 4 µm POLAR-RP 250 x 4.6 mm i.d. reverse 
phase column (Phenomenex, Macclesfield, UK). Injections were carried out with 
an autosampler maintained at 4°C. The mobile phase was pumped at a flow rate 
of 1 ml/min. The column eluate initially passed through the PDA detector and 
was then split, and 0.3 ml/min directed to the mass spectrometer with ESI 
operating in full scan negative ionisation mode (100-1000 m/z). Analyses of 
Page 16 of 35Food & Function
 17
coffee, plasma and urine samples were initially carried out using full scan, data 
dependent MS2 scanning from m/z 100 to 1000. The tuning of the mass 
spectrometer was optimised by infusing a standard of ferulic acid, dissolved in 
the initial HPLC mobile phase, into the source at a flow rate of 0.3 ml/min. 
Capillary temperature was 300ºC, sheath gas and auxiliary gas were 80 and 60 
units/min respectively, and source voltage was 3.0 kV, and collision energy set at 
35 %. 
Separation of coffee chlorogenic acids was achieved on a 110-min 
gradient of 5-25 % acetonitrile in 0.1 % aqueous formic acid. Following 
separation, hydroxycinnamates were detected and quantified with the PDA at 
325 nm, and identification was confirmed by mass spectrometry using 
consecutive reaction monitoring (CRM). Mean data are expressed as µmol ± SE 
(n = 3) of 5-CQA equivalents for the CQAs, FQAs, di-CQAs, and p-CoQAs, and as 
µmol ± SE (n = 3) of 3-CQAL and 4-CQAL for the respective lactones quantified. 
Plasma and urine were analysed using a 40 min, 5-16 % gradient of 
acetonitrile in 0.5 % aqueous acetic acid. Following separation, 
hydroxycinnamates and metabolites were quantified using selective ion 
monitoring (SIM), based on the calibration curves of the corresponding standard. 
Sulphated ferulic, isoferulic, caffeic, dihydroferulic, and dihydrocaffeic acids were 
quantified based on the SIM calibration curves of the respective O-sulphated 
standards. Sulphated 3- and 4-caffeoylquinic acid lactones were quantified based 
on the SIM calibration curves for 3- and 4-CQAL, respectively. Feruloylglycine 
was quantified based on the calibration curve of ferulic acid at 325 nm, as the 
glycine derivative, like ferulic acid, had a λmax at this wavelength. Quantification 
of FQAs was based on the SIM calibration curve of 5-CQA. Glucuronidated 
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isoferulic acid, dihydroferulic acid, dihydro(iso)ferulic and dihydrocaffeic acids 
were quantified based on SIM calibration curves of authentic isoferulic-, 
dihydroferulic- and dihydrocaffeic acid-O-glucuronides, respectively. Data are 
expressed as mean values ± SE (n = 11), in µmol for urine and nM for plasma.  
Calibration curves of standards used to quantify chlorogenic acids and 
derivatives in various samples were drawn from the analysis of 5 µl volumes at 
concentrations ranging from 0.1 to 100 ng/µl (n = 7) for coffee samples, and 0.2 
to 20 ng/µl (n = 5) for plasma and urine samples.  Coefficients of linearity for the 
calibration curves were typically R2 > 0.99.  The limits of detection as monitored 
on PDA (at 325 nm for chlorogenic acids and hydroxycinnamates, and 280 nm 
for dihydrocaffeic acid and dihydroferrulic acid) and SIM were determined by 
analysis in triplicate of standards at low concentrations. Typical limits of 
detection for PDA were 0.5 ng (CV 4.6-22 %), and 0.1 ng (CV 5.6-33 %) for SIM, 
except for isoferulic acid where a 5 ng limit of detection (CV 23 %) was obtained 
with SIM at m/z 193, as the acid content of the mobile phase suppresses 
ionization.31 
4.5. Pharmacokinetic analysis of chlorogenic acids and their metabolites 
in plasma   
Statistical comparison of the amounts of chlorogenic acids contained in a 200 ml 
– serving of coffee was achieved using One-way ANOVA. Normality of the data on 
the pharmacokinetic parameters was assessed using the Shapiro-Wilk test. As 
the data was not normally distributed, non-parametric statistical tests were used 
and data are reported as median and interquartiles (Q1; Q3).  Statistical analyses 
testing differences between the three groups for urinary excretion and plasma 
pharmacokinetic data following increasing doses of chlorogenic acids ingested 
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were performed using Friedman test, followed by pairwise post hoc 
comparisons. Correlative association between increased doses of chlorogenic 
acid ingested and levels of plasma and urine metabolites was investigated using 
Spearman’s rank coefficient correlations (IBM®, SPSS® Statistics, Version 21). 
Statistical significance was set at P-value < 0.05. 
5. Conclusions 
Coffee is a rich source of chlorogenic acids, principally 5-CQA, 4-CQA and 3-CQA. 
Analysis of plasma after the acute ingestion of coffees containing increasing 
amounts of chlorogenic acids of 412, 635 and 795 µmol revealed the presence 13 
metabolites and parent compounds.  Although FQAs were detected in plasma but 
only trace amounts of 5-CQA were present.  5-CQA and the FQAs all had plasma 
Tmax times of ~1.0 h indicative of absorption in the small intestine.  The main 
circulatory metabolites absorbed in the small intestine were caffeic acid-3′-O-
sulphate and ferulic acid-4′-O-sulphate.  The ferulic acid sulphate had a second 
Tmax of 4 h in keeping with colonic absorption.  The other plasma metabolites 
originating from the colon were dihydroferulic acid, dihydrocaffeic acid, 
dihydroferulic acid-4′-O-sulphate and dihydrocaffeic acid-3’-O-sulphate.  Overall 
there was a trend, albeit with several exceptions, for increased levels of plasma 
metabolites with increasing intakes of chlorogenic acids. In contrast, the 
cumulative 0-24h urinary excretion of 16 metabolites ranged 15.7 to 25.2% of 
chlorogenic acid intake. The excretion level when expressed as a percentage of 
intake was not significantly different for the three coffees. However, when 
divided into metabolites absorbed in the small intestine and large intestine, at 
the highest dose there is a significant trend towards lower absorption in the 
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small intestine that is not reflected to the same extent with the colonic 
metabolites. Although not major metabolites, the levels of FQAs and CQAL-O-
sulphates in plasma and urine did increase significantly and positively correlate 
with the ingested dose of chlorogenic acids.  These compounds are therefore 
good, specific biomarkers of the extent of coffee consumption, even at low 
intakes. Further work should be carried out to determine the suitability of these 
compounds as biomarkers of chlorogenic acids/coffee intake in a wider 
population of free-living individuals without any dietary restrictions. 
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Figure Legends 
 
Fig. 1  Pharmacokinetic profiles of chlorogenic acid derivatives and metabolites 
in the plasma of human subjects 0-24 h after the ingestion of 200 mL of instant 
coffee containing 412 (yellow line), 635 (blue line) and 795 (red line) µmol of 
chlorogenic acids. Data expressed as mean values. 
Fig. 2  Box-and-Whisker plots representing median, range and interquartile values 
of 24-h urinary excretion for 3-FQA, 4-FQA and 5-FQA after intake of increasing 
doses of the parents compounds by healthy volunteers (n = 11). 
Fig. 3  Median and interquartile values of peak plasma concentrations for 3-FQA, 
4-FQA, 5-FQA, 3-CQAL sulphate and 4-CQAL sulphate after intake of increasing 
doses of the parents compounds by healthy volunteers (n = 11). 
Fig. 4  Median and interquartile values of peak plasma concentrations for 3-FQA, 
4-FQA, 5-FQA, 3-CQAL sulphate and 4-CQAL sulphate after intake of increasing 
doses of the parents compounds by healthy volunteers (n = 11). 
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Table 1  Quantification of chlorogenic acids in 200 mL servings of the three 
different coffee beverages fed to healthy volunteersa 
Compounds Coffee I Coffee II Coffee III 
3-Caffeoylquinic acid 72 ± 1.3 † 101 ± 0.5 * 96 ± 2.6 * 
4-Caffeoylquinic acid 78 ± 1.5 † 114 ± 1.3 * 114 ± 3.3 * 
5-Caffeoylquinic acid 119 ± 2.1 ‡ 186 ± 1.2 † 373 ± 8.3 * 
Total Caffeoylquinic acids 269 ± 4.9 ‡ 401 ± 3.0 † 583 ± 14 * 
3-Feruloylquinic acid 20 ± 1.6 * 30 ± 0.3 † 17 ± 0.3 * 
4-Feruloylquinic acid 22 ± 1.8 * 40 ± 0.4 † 21 ± 0.0 * 
5-Feruloylquinic acid 25 ± 1.9 ‡ 47 ± 0.5 † 65 ± 0.1 * 
Total Feruloylquinic acids 67 ± 5.3 ‡ 117 ± 1.3 † 103 ± 0.3 * 
3-Caffeoylquinic acid lactone 34 ± 2.9 ‡ 46 ± 0.5 † 23 ± 0.1 * 
4-Caffeoylquinic acid lactone 23 ± 2.0 ‡ 32 ± 0.4 † 16 ± 0.1 * 
Total Caffeoylquinic acid lactones 57 ± 4.9 ‡ 77 ± 0.9 † 40 ± 0.1 * 
4-p-Coumaroylquinic acid 3.8 ± 0.1 † 4.0 ± 0.1 † 3.2 ± 0.0 * 
5-p-Coumaroylquinic acid 3.1 ± 0.1 † 3.1 ± 0.0 † 4.8 ± 0.0 * 
Total p-Coumaroylquinic acids 6.8 ± 0.1 † 7.1 ± 0.1 † 8.1 ± 0.0 * 
3,4-Dicaffeoylquinic acid 5.8 ± 0.6 ‡ 13 ± 0.5 † 23 ± 0.1 * 
3,5-Dicaffeoylquinic acid 2.8 ± 0.3 ‡ 8.1 ± 0.8 † 17 ± 0.1 * 
4,5-Dicaffeoylquinic acid 4.0 ± 0.4 ‡ 11 ± 0.4 † 21 ± 0.1 * 
Total Dicaffeoylquinic acids 13 ± 1.2 ‡ 32 ± 1.7 † 61 ± 0.3 * 
Total chlorogenic acids 412 ± 9 ‡ 635 ± 3 † 795 ± 14 * 
a Data expressed as mean values ± SE (n = 3) in μmol of 5-CQA equivalents for the CQAs, FQAs, p-
CoQAs and diCQAs, and 3- and 4-CQAL equivalents for the lactones 
Different superscripts within rows indicate statistical difference (One-Way ANOVA, P < 0.05) 
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Table 2  HPLC-MSn identification of chlorogenic acids and metabolites detected in plasma and urine of human volunteers 0-24 h 
following the ingestion of 200 mL of coffee a 
Peak 
Rt 
(min) 
[M-H]– 
(m/z) 
MS2 (m/z) MS3 (m/z) Compounds Identified Location 
1 7.2 433 353 191, 179, 135 3-Caffeoylquinic acid-O-sulphate Urine (traces) 
2 10.3 261 181 137, 119 Dihydrocaffeic acid-3-O-sulphate Plasma, Urine 
3 11.1 357 181, 175, 137, 113 - Dihydrocaffeic acid-3-O-glucuronide Urine 
4 11.2 433 353 191, 179, 173, 135 4-Caffeoylquinic acid-O-sulphate Urine (traces) 
5 11.7 259 179 135 Caffeic acid-4′-O-sulphate Urine (traces in plasma) 
6 12.1 275 195 177, 151, 136, 135, 123, 119 Dihydroferulic acid-4′-O-sulphate Plasma, Urine 
7 12.8 259 179 135 Caffeic acid-3′-O-sulphate Plasma, Urine 
8 13.5 181 137, 119  Dihydrocaffeic acid Plasma (traces in urine) 
9 13.9 371 195, 175, 113 - Dihydroferulic acid-4′-O-glucuronide Urine (traces in plasma) 
10 14.5 273 193 178, 149, 134 Ferulic acid-4′-O-sulphate Plasma, Urine 
11 15.4 353 191 - 5-Caffeoylquinic acid Plasma 
12 16.5 367 193 - 3-Feruloylquinic acid Plasma, Urine 
13 16.9 273 193 178 Isoferulic acid-3′-O-sulphate Urine (traces in plasma) 
14 17.7 371 195, 175, 113 - Dihydro(iso)ferulic acid-3′-O-glucuronide Urine 
15 19.6 369 193, 175, 113 - Isoferulic acid-3′-O-glucuronide Urine (traces in plasma) 
16 21.9 250 206, 191, 177, 149, 100 - Feruloylglycine Urine 
17 22.4 415 335 161, 135 3-Caffeoylquinic acid lactone-O-sulphate Plasma, Urine 
18 22.9 415 335 161, 135 4-Caffeoylquinic acid lactone-O-sulphate Plasma, Urine 
19 24.6 367 173, 193 - 4-Feruloylquinic acid Plasma, Urine 
20 26.4 195 177, 151, 136, 135, 123, 119 - Dihydroferulic acid Plasma, Urine 
21 27.4 367 191 - 5-Feruloylquinic acid Plasma, Urine 
aRt, retention time; [M-H]–, negatively charged molecular ion; MS2, daughter ions produced from [M-H]– fragmentation; MS3, daughter ions produced from 
fragmentation of MS2 base ion 
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Table 3   Pharmacokinetic parameters of chlorogenic acid derivatives and metabolites circulating in plasma of volunteers 0-24 h following the 
ingestion of coffees containing 412, 635 and 795, µmol of chlorogenic acids a 
Metabolites 
Cmax (nM) Tmax (h) AUC (nmol.h.L-1) T1/2 (h) 
412 μmol 635 μmol 795 μmol 412 μmol 635 μmol 795 μmol 412 μmol 635 μmol 795 μmol 412 μmol 635 μmol 795 μmol 
3-Caffeoylquinic acid lactone-O-
sulphate 
27*† 
(20; 35) 
54† 
(35; 75) 
20* 
(16; 29) 
0.5 
(0.5; 0.75) 
0.5 
(0.5; 0.5) 
0.5 
(0.5; 0.5) 
26*† 
(20; 40) 
69† 
(45; 91) 
21* 
(14; 27) 
0.5 
(0.3; 0.5) 
0.5 
(0.5; 0.6) 
0.3 
(0.2; 0.5) 
4-Caffeoylquinic acid lactone-O-
sulphate 
21*† 
(15; 26) 
51† 
(30; 72) 
18* 
(13; 22) 
0.5 
(0.5; 0.9) 
0.5 
(0.5; 0.5) 
0.5 
(0.5; 0.5) 
21* 
(16; 31) 
72† 
(37; 77) 
18* 
(11; 23) 
0.5 
(0.4; 0.5) 
0.5 
(0.5; 0.6) 
0.3 
(0.1; 0.6) 
Caffeic acid-3′-O-sulphate 
90 
(70; 108) 
89 
(67; 162) 
79 
(60; 107) 
1.0 
(0.5; 1.3) 
1.0 
(0.8; 1.0) 
0.5 
(0.5; 1.0) 
227 
(181; 377) 
359 
(219; 438) 
184 
(123; 426) 
1.2 
(0.8; 3.4) 
1.2 
(0.7; 1.4) 
0.9 
(0.7; 1.1) 
3-Feruloylquinic acid 
16*† 
(13; 17) 
43* 
(29; 46) 
13† 
(10; 16) 
0.5 
(0.5; 1.0) 
1.0 
(0.5; 1.0) 
0.5 
(0.5; 1.3) 
25* 
(23; 33) 
78† 
(53; 102) 
24* 
(20; 25) 
0.9 
(0.7; 1.1) 
1.0 
(0.7; 1.0) 
1.0 
(0.8; 1.3) 
4-Feruloylquinic acid 
14*† 
(8.4; 18) 
24* 
(21; 45) 
9.2† 
(7.7; 13) 
1.0 
(0.5; 1.0) 
1.0 
(0.8; 1.0) 
1.0 
(0.5; 1.3) 
20* 
(18; 33) 
55† 
(35; 98) 
19* 
(15; 27) 
0.8 
(0.6; 0.9) 
1.0 
(0.8; 1.2) 
0.9 
(0.8; 1.4) 
5-Feruloylquinic acid 
5.4* 
(4.5; 5.9) 
12*† 
(10; 14) 
18† 
(15; 22) 
1.0 
(0.6; 1.0) 
1.0 
(0.6; 1.0) 
1.0 
(1.0; 1.5) 
7.9* 
(6.4; 9.1) 
19*† 
(16; 22) 
38† 
(29; 45) 
0.8 
(0.6; 1.0) 
0.8 
(0.5; 1.0) 
1.1 
(0.8; 1.3) 
5-Caffeoylquinic acid 
5.9 
(5.0; 7.0) 
10 
(6.6; 13) 
11 
(5.9; 13) 
1.0 
(0.9; 1.1) 
0.5 
(0.5; 1.0) 
1.0 
(0.5; 1.0) 
5.2 
(4.2; 12) 
7.5 
(5.7; 8.9) 
14.7 
(5.6; 23) 
0.3 
(0.2; 1.0) 
0.2 
(0.2; 0.3) 
0.6 
(0.4; 0.6) 
Ferulic acid-4′-O-sulphate b 
65* 
(61; 90) 
126† 
(111; 195) 
68* 
(47; 94) 
0.5 
(0.5; 0.5) 
0.5 
(0.5; 0.5) 
0.5 
(0.5; 0.5) 
- - - 
1.2 
(1.0; 1.4) 
1.1 
(0.8; 1.3) 
1.1 
(0.8; 1.2) 
Total (small intestine absorption) 
261 
(187;319) 
510 
(336;570) 
244 
(205;297) 
- - - - - - - - - 
Ferulic acid-4′-O-sulphate b 
33* 
(26; 41) 
54† 
(44; 73) 
35*† 
(26; 73) 
4.0 
(4.0; 4.0) 
4.0 
(3.5; 4.0) 
4.0 
(4.0; 6.0) 
409* 
(349; 447) 
703† 
(601; 791) 
511*† 
(292; 894) 
3.6 
(3.3; 4.7) 
3.2 
(2.6; 7.2) 
3.9 
(3.0; 8.4) 
Dihydrocaffeic acid 
49 
(34; 54) 
56 
(39; 101) 
72 
(56; 102) 
6.0 
(4.0; 6.0) 
6.0 
(6.0; 6.0) 
6.0 
(6.0; 7.5) 
118 
(92; 209) 
481 
(333; 604) 
631 
(230; 989) 
0.7 
(0.4; 0.8) 
3.0 
(2.6; 3.5) 
2.7 
(1.1; 2.9) 
Dihydrocaffeic acid-3′-O-sulphate 
220 
(107; 429) 
465 
(174; 772) 
409 
(318; 678) 
6.0 
(4.0; 6.0) 
6.0 
(6.0; 7.0) 
6.0 
(6.0; 6.0) 
1787* 
(712; 3210) 
3768† 
(2070; 5062) 
3839† 
(3002; 7302) 
2.7 
(2.3; 3.9) 
2.4 
(2.0; 3.9) 
2.1 
(1.9; 2.2) 
Dihydroferulic acid 
375 
(344; 587) 
463 
(330; 620) 
518 
(462; 771) 
4.0 
(4.0; 6.0) 
5.0 
(4.0, 7.5) 
6.0 
(6.0; 6.0) 
2845* 
(2255; 3210) 
3792*† 
(2497; 4797) 
4549† 
(3688; 7834) 
2.1 
(1.9; 2.2) 
2.1 
(2.0; 2.2) 
2.0 
(1.8; 2.0) 
Dihydroferulic acid-4′-O-sulphate 
88 
(44; 166) 
98 
(46; 172) 
117 
(80; 327) 
6.0 
(4.0; 6.0) 
6.0 
(5.0; 8.0) 
6.0 
(6.0; 6.0) 
834 
(264; 1132) 
1189 
(368; 1591) 
1043 
(780; 3574) 
3.3 
(2.5; 7.2) 
3.5 
(2.6; 5.3) 
2.9 
(2.6; 4.1) 
Total (large intestine  absorption) 
808 c 
(470; 1119) 
1242 c 
(669; 1594) 
1164 c 
(926; 1900) 
- - - - - - - - - 
a Data expressed as median and interquartiles (Q1; Q3) values (n = 11). Cmax, maximum plasma concentration; Tmax, time corresponding to Cmax; AUC, area under the curve 
(0-24 h); T1/2, elimination half-life 
b Double values indicate pharmacokinetic parameters associated with first and second peak plasma concentrations (see Figure 1) 
Different superscripts within rows indicate a statistical difference (Friedman’s Analysis of Variance with pair-wise post-hoc comparison, P < 0.05) 
c Statistically significant trend between the groups (P < 0.05) but no pair-wise significance  
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Table 4   Quantities of urinary chlorogenic acid derivatives and metabolites excreted by volunteers (0-24 h), following the ingestion of 
coffees containing 412, 635 and 795, µmol of chlorogenic acids a 
Metabolites excreted 
Dose ingested 
412 μmol 635 μmol 795 μmol 
Small intestine absorption    
Caffeic acid-O-sulphates (2) 6.2 (5.5; 7.6) (1.5 %) * 5.8 (5.1; 7.2) (0.9 %) *† 4.3 (3.3; 5.6) (0.5 %) † 
Isoferulic acid-3′-O-sulphate 0.3 (0.2; 0.4) (0.1 %) 0.4 (0.3; 0.7) (0.1 %) 0.4 (0.3; 0.5) (0.1 %) 
Isoferulic acid-3′-O-glucuronide 5.0 (3.7; 5.3) (1.2 %) 7.1 (5.4; 11.3) (1.4 %) 7.7 (5.6; 11.7) (1.1 %) 
Ferulic acid-4ʹ-O-sulphate 9.9 (7.3; 13.7) (2.4 %) C 14.4 (12.3; 26.7) (2.3 %) C 16.1 (12.3; 24.8) (2.0 %) C 
3-Caffeoylquinic acid lactone-O-sulphate b 1.0 (0.9; 1.3) (3.0 %) 1.0 (1.0; 1.4) (2.3 %) 0.7 (0.6; 0.8) (3.0 %) 
4-Caffeoylquinic acid lactone-O-sulphate b 0.8 (0.7; 1.1) (3.6 %) * 0.8 (0.7; 0.9) (2.6 %) † 0.5 (0.5; 0.6) (3.3 %) *† 
3-Caffeoylquinic acid-O-sulphate b 0.0 (0.0; 0.1) (< 0.1 %) 0.1 (0.0; 0.1) (< 0.1 %) 0.0(0.0; 0.0) (< 0.1%) 
4-Caffeoylquinic acid-O-sulphate b 0.1 (0.0; 0.1) (< 0.1 %) 0.0 (0.0; 0.1) (< 0.1 %) 0.0 (0.0; 0.0) (< 0.1%) 
3-Feruloylquinic acid b 1.2 (0.8; 1.4) (5.1 %) 1.6 (1.3; 2.3) (6.2 %) 0.7 (0.6; 0.9) (4.4 %) 
4-Feruloylquinic acid b 1.2 (0.9; 1.4) (5.3 %) * 1.1 (0.8; 1.7) (2.7 %) † 0.7 (0.4; 0.8) (3.1 %) † 
5-Feruloylquinic acid b 0.8 (0.6; 1.0) (3.3 %) * 0.9 (0.7; 1.1) (1.8 %) † 1.4 (1.1; 1.6) (2.2 %) *† 
Total excretion after small intestine absorption 24.4 (23.7; 33.5) (5.9 %) * 34.4 (30.0; 54.9) (5.4 %) * 31.2 (26.0; 43.7) (3.9 %) † 
    
Large intestine absorption    
Dihydrocaffeic acid-3′-O-sulphate 35.7 (16.3; 43.0) (8.7 %) 47.4 (27.8; 71.2) (7.5 %) 47.9 (36.6; 89.9) (6.0 %) 
Dihydroferulic acid 8.7 (4.1; 15.0) (2.1 %) 9.2 (7.0; 18.9) (1.5 %) 10.6 (6.8; 18.7) (1.3 %) 
Dihydroferulic acid-4′-O-sulphate 11.4 (5.4; 13.9) (2.8 %) 12.4 (3.4; 22.5) (2.0 %) 17.5 (6.5; 25.8) (2.2 %) 
Feruloylglycine 18.7 (10.9; 26.4) (4.5 %) 26.2 (17.5; 29.9) (4.1 %) 27.2 (24.6; 38.9) (3.4 %) 
Total excretion after large intestine absorption 76.3 (50.4; 95.5) (18.5 %) 127.7 (60.2; 155.2) (20.1%) 95.6 (83.6; 189.0) (12.0%) 
Total excretion 100.7 (82.2; 119.3) (24.4 %) 160.0 (90.7; 211.1) (25.2 %) 125.2 (109.3; 241.0) (15.7 %) 
a Data expressed as median values and interquartiles (Q1; Q3) values (n = 11) in μmol. Italicised figures in brackets represent the amount excreted as a 
percentage of the dose ingested 
b Expressed as a percentage of FQAs, CQALs and CQAs contained in coffee beverages 
Different superscripts within rows indicate a statistical difference (Friedman’s Analysis of Variance with pair-wise post-hoc comparison, P < 0.05) 
c Statistically significant trend between the groups (P < 0.05) but no pair-wise significance  
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Table 5 Spearman’s rank coefficient correlation between plasma and urinary metabolites 
and chlorogenic acid levels after increased doses ingested 
Metabolites Plasma a Urine b 
Rho p-value Rho p-value 
3-Caffeoylquinic acid lactone-O-sulphate c 0.596 0.000 0.643 0.000 
4-Caffeoylquinic acid lactone-O-sulphate c 0.623 0.000 0.577 0.000 
Caffeic acid-3′-O-sulphate d -0.074 0.682 -0.382 0.028 
Ferulic acid-4′-O-sulphate d 0.047 0.796 0.409 0.018 
Isoferulic acid-3′-O-sulphate d nd nd 0.312 0.077 
Isoferulic acid-3′-O-glucuronide d nd nd 0.507 0.003 
3-Caffeoylquinic acid-O-sulphate c nd nd 0.115 0.525 
4-Caffeoylquinic acid-O-sulphate c nd nd -0.222 0.213 
3-Feruloylquinic acid c 0.807 0.000 0.733 0.000 
4-Feruloylquinic acid c 0.670 0.000 0.526 0.002 
5-Feruloylquinic acid c 0.719 0.000 0.362 0.038 
5-Caffeoylquinic acid c 0.334 0.150 nd nd 
Dihydrocaffeic acid d 0.337 0.069 nd nd 
Dihydrocaffeic acid-3′-O-sulphate d 0.307 0.087 0.355 0.043 
Dihydroferulic acid d 0.227 0.227 0.214 0.231 
Dihydroferulic acid-4′-O-sulphate d 0.178 0.331 0.355 0.043 
Feruloylglycine d nd nd 0.335 0.057 
a Based on Cmax values in nM 
b Based on 24-h urinary excretion in µmol 
c Intake based on amount of individual chlorogenic acid ingested 
d Intake based on total amount of chlorogenic acid ingested 
nd; not detected 
 
 
Table 6 Peak plasma concentration and urinary excretion of metabolites absorbed in the 
small intestine and the large intestine, expressed as median values and as percentages of 
total chlorogenic acid ingested 
  Chlorogenic acid doses p-values 
  412 µmol 635 µmol 795 µmol  
Plasma Cmax (nM) Small intestine 261.4 510.1 243.7 0.086 
 Large intestine 808.4a 1241.8a 1164.1a 0.035 
 SI + LI 1088* 1526† 1352*† 0.009 
      
      
      
Urine excretion (µmol) Small intestine 24.4* 38.4† 31.2*† 0.012 
 Large intestine 76.3 127.7 95.6 0.060 
 SI + LI 100.47 160.0 125.2 0.012 
Urine excretion (%) Small intestine 5.9* 5.4* 3.9† 0.001 
 Large intestine 18.5 20.1 12.0 0.307 
 SI + LI 24.4 25.2 15.7 0.178 
Different superscripts within rows indicate a statistical difference (Friedman’s Analysis of Variance with 
pair-wise post-hoc comparison, P < 0.05) 
a Statistically significant trend between the groups (P < 0.05) but no pair-wise significance 
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Fig. 1  Pharmacokinetic profiles of chlorogenic acid derivatives and metabolites in the plasma of human 
subjects 0-24 h after the ingestion of 200 mL of instant coffee containing 412 (yellow line), 635 (blue line) 
and 795 (red line) µmol of chlorogenic acids. Data expressed as mean values.  
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Fig. 2  Box-and-Whisker plots representing median, range and interquartile values of 24-h urinary excretion 
for 3-FQA, 4-FQA and 5-FQA after intake of increasing doses of the parents compounds by healthy 
volunteers (n = 11).  
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Fig. 3  Median and interquartile values of peak plasma concentrations for 3-FQA, 4-FQA, 5-FQA, 3-CQAL 
sulphate and 4-CQAL sulphate after intake of increasing doses of the parents compounds by healthy 
volunteers (n = 11).  
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Fig. 4  Median and interquartile values of peak plasma concentrations for 3-FQA, 4-FQA, 5-FQA, 3-CQAL 
sulphate and 4-CQAL sulphate after intake of increasing doses of the parents compounds by healthy 
volunteers (n = 11).  
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Impact of dose on the bioavailability of coffee 
chlorogenic acids in humans 
 
Angélique Stalmach, Gary Williamson and Alan Crozier 
 
 
This article reports and investigation of the effect of dose on the bioavailability of 
chlorogenic acids in humans based on HPLC-MS
2
 and analysis of plasma and urine 
collected 0-24 h after supplementation 
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